The data to fight cancer is

In this Image.

Look closer...

For 150 years, pathology was limited to what a single observer could see under a microscope. But in a future of computational medicine, data from billions of images will give humans a perspective never before possible.

Proscia is ready for that future today.

We’ve created a digital pathology platform that enables pathologists and researchers to leverage the pathology data in every slide. Our software turns pixels into patterns and insights that will change the way humans look at cancer.

Data Management

Secure cloud infrastructure integrates with all whole slide scanners

Collaboration

Collaborate with pathologists around the world in real time

Image analysis

Extract data from tissue with powerful quantification algorithms

The laboratory of tomorrow

Won't be a lab at all.

Digital pathology is making it possible to break down the walls between labs — unlocking new kinds of data and tools for medical science professionals to fight cancer.

Proscia has begun that work with tissue intelligence technology that is already connecting lab efforts worldwide. This AI-powered software is helping them identify patterns not visible under a single microscope — and that’s just the start of what we have planned.

With the help of partners

We can move forward faster

With best-in-class image analysis applications, Proscia's tissue intelligence technology enables the development of new types of cancer research and diagnostic tools.

If you are committed to advancing pathology and want to make sense of your data, we'd like to talk.

Webinar: The Whys and Hows of Adopting Digital Pathology

Join Leica Biosystems and Proscia Digital Pathology as they discuss why institutions are going digital today and how they approach best practices in digital pathology implementation.

Watch the Full Webinar

Proteocyte AI Leverages Proscia Digital Pathology Platform to Predict Risk of Oral Cancer

Merging of technologies will help pathologists and doctors give more effective prognostic assessments than current standard of care.

Proscia, Inc. Named to 2017 Entrepreneur360™ List

Proscia has been named to the 2017 Entreprenuer360™ list by Entrepreneur magazine — a ranking of the top entrepreneurial companies in America.

Proscia Inks Agreement to Bring Deep-Learning Technology to Dermatopathology

Landmark agreement positions Proscia to transform dermatopathology market − and opens doors to additional lab partnerships.